arrow
P

Per Ljungman

ebmt infectious disease working party
H指数:110
被引数:4.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Syndrome-oriented CNS infectious complications after hematopoietic stem-cell transplantation and CAR T-cell therapy, part 1—viral encephalitis, meningitis, and myelitis: recommendations from the Practice Harmonization & Guidelines Committee of the EBMT

造血干细胞移植和CAR T细胞治疗后中枢神经系统感染并发症的综合征导向性研究,第一部分——病毒性脑炎、脑膜炎和脊髓炎:来自EBMT实践协调与指南委员会的建议

2026-11-050
OA
Comprehensive molecular characterization of treatment-free remission and molecular relapse in chronic myeloid leukemia patients: the EURO-SKI Biomarker Study

慢性髓性白血病患者治疗中断缓解和分子学复发的全面分子特征分析:EURO-SKI生物标志物研究

Leukemia
IF13.4
2026-06-180
OAAI
Central nervous system complications after allogeneic haematopoietic cell transplantation: best practice recommendations from the EBMT practice harmonisation and guidelines committee on epidemiology, outcome and neuroimaging

异基因造血细胞移植后的中枢神经系统并发症:EBMT实践协调和指南委员会关于流行病学、结局和神经影像学的最佳实践建议

2026-05-130
PRE
Symptom-guided approach to central nervous system complications in allogeneic hematopoietic cell transplant recipients: Best practice recommendations from the EBMT Practice Harmonisation and Guidelines committee

症状指导方法在异基因造血细胞移植受者中枢神经系统并发症中的应用:EBMT实践协调和指南委员会的最佳实践建议

2026-05-070
PRE
Impact of donor and recipient EBV serostatus on transplant outcomes in patients with acute leukemia after haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide: Infectious Diseases Working Party EBMT retrospective study

供体和受者EBV血清状态对异基因造血细胞移植后环磷酰胺治疗的急性白血病患者移植结局的影响:EBMT感染性疾病工作组回顾性研究

2026-05-040
PRE
Overcoming barriers to adult immunization in Europe: A decalogue for policy action by the Adult Immunization Board

克服欧洲成人疫苗接种的障碍:成人疫苗接种委员会的政策行动十点纲领

2026-02-170
OAAI
Syndrome-oriented CNS infectious complications after haematopoietic stem-cell transplantation and CAR T-cell therapy, part 2—focal brain infections and meningitis of bacterial, fungal, and parasitic origin: recommendations from the EBMT Practice and Harmonization Committee

造血干细胞移植和CAR T细胞治疗后以综合征为导向的中枢神经系统感染并发症,第2部分——细菌性、真菌性和寄生虫性局灶性脑感染和脑膜炎:EBMT实践与协调委员会的建议

2026-01-010
OA
Community-acquired respiratory virus infections in patients with haematological malignancies or undergoing haematopoietic cell transplantation: updated recommendations from the 10th European Conference on Infections in Leukaemia

血液系统恶性肿瘤患者或造血细胞移植受者中的社区获得性呼吸道病毒感染:第10届欧洲白血病感染会议更新建议

2025-08-270
OAAI
Advancing the Integration of ‘Basic/Fundamental’ and Translational Cellular and Gene Therapy Science within the EBMT: Accelerating the Pathway to Progress

推进EBMT内“基础/根本”与转化细胞及基因治疗科学的整合:加速通往进步的路径

2025-08-070
PRE
Author’s Reply to the correspondence: ECIL-10 guidelines for COVID-19 should take convalescent plasma into proper consideration by Focosi et al.

作者对来函的回复:ECIL-10关于COVID-19的指南应适当考虑康复血浆的应用(Focosi等人)

Leukemia
IF13.4
2025-08-040
PRE
Defining Bloodstream and Central Venous Catheter-Related Infections in Patients Following Haematopoietic Cell Transplantation: Position Paper of the EBMT Infectious Diseases Working Party and Practice Harmonization and Guidelines Committee

定义造血细胞移植后患者血液感染和中心静脉导管相关感染的诊断标准:EBMT感染性疾病工作组与实践协调及指南委员会立场文件

2025-07-210
PRE
Pneumonia definition in allogeneic hematopoietic cell transplant recipients: Update and challenges in 2024. Recommendations from the EBMT Infectious Diseases Working Party and Practice Harmonization and Guidelines committee

同种异基因造血细胞移植受者肺炎的定义:2024年更新与挑战。欧洲血液与骨髓移植集团感染性疾病工作组与实践协调及指南委员会的建议

2025-07-010
OAAI
Clinical characteristic and outcome of HHV-6 encephalitis after allogeneic hematopoietic cell transplantation: A study of Infectious Disease Working Party of EBMT

同种异基因造血细胞移植后HHV-6脑炎的临床特征与结局:EBMT感染性疾病工作组的研究

2025-06-030
PRE
Post-pandemic recommendations for the management of COVID-19 in patients with haematological malignancies or undergoing cellular therapy, from the European Conference on Infections in Leukaemia (ECIL-10)

后疫情时代针对血液恶性肿瘤患者或接受细胞治疗患者的COVID-19管理建议,源自欧洲白血病感染会议(ECIL-10)

Leukemia
IF13.4
2025-06-020
OAAI
An ASTCT, CIBMTR, EBMT, and APBMT Consensus Statement Defining Response Criteria for Hematopoietic Cell Transplantation Associated Thrombotic Microangiopathy (TA-TMA) Directed Therapy

ASTCT、CIBMTR、EBMT和APBMT关于造血细胞移植相关血栓性微血管病(TA-TMA)导向治疗反应标准的共识声明

2025-06-010
OAAI
Refractory and Resistant Herpes Simplex Virus Mucocutaneous Infections in Immunocompromised Patients: Literature Review and Proposed Definitions for Use in Clinical Trials

免疫功能低下患者难治性和耐药性单纯疱疹病毒黏膜皮肤感染:文献综述及临床试验中拟用定义

2025-01-291
OA
Real-world assessment of immunogenicity in immunocompromised individuals following SARS-CoV-2 mRNA vaccination: a two-year follow-up of the prospective clinical trial COVAXID
2024-11-010
PRE